β-catenin nuclear accumulation in head and neck mucoepidermoid carcinoma

Its role in cyclin D1 overexpression and tumor progression

Hideki Shiratsuchi, Torahiko Nakashima, Naoya Hirakawa, Satoshi Toh, Takashi Nakagawa, Tsuyoshi Saito, Masazumi Tsuneyoshi, Shizuo Komune

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background. Nuclear/cytoplasmic accumulation of β-catenin is mainly regulated by its degradation, which is initiated by interaction with adenomatous polyposis coli (APC) protein. Accumulation of β-catenin activates the transcription of 1 of the target oncogenic genes, cyclin D1, in the Wnt/Wingless pathway. The role of β-catenin and cyclin D1 in this pathway has not been previously studied in head and neck mucoepidermoid carcinoma (MEC). This study investigates abnormalities of β-catenin and the APC gene in MEC and correlates the patterns of cyclin D1 overexpression and nuclear/cytoplasmic accumulation of β-catenin with the clinical outcome. Methods. Mutations of the β-catenin and APC genes, as well as overexpression of cyclin D1, were investigated by polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) in tissue samples from 44 cases of MEC. In addition, we employed differential PCR method to detect amplification of the cyclin D1 gene. Furthermore, the overexpression of cyclin D1 and nuclear/cytoplasmic accumulation of β-catenin was examined by immunohistochemistry, and any correlation with clinicopathologic parameters was evaluated. Results. Nuclear/cytoplasmic accumulation of β-catenin was observed in 6 of 44 MEC cases (13.6%), 5 of which were high-grade MEC, while the other 1 case was intermediate-grade tumor. Mutational analysis of exon 3 of the β-catenin gene revealed that 4 of 26 cases (15.4%) contained point mutations (3 in codon 32, GAC [Asp] to GGC [Gly]; 1 in codon 42, ACA [Thr] to ATA [Ile]), and all these 4 cases showed β-catenin accumulation immunohistochemically. The nuclear/cytoplasmic accumulation of β-catenin was significantly correlated with the adverse outcome of patients (p = .011). Two APC gene alterations were detected in 2 cases of low-grade MEC, where there was no β-catenin nuclear accumulation. Amplification of the cyclin D1 gene was observed in 10 of 26 cases (38.5%). Cyclin D1 overexpression was recognized in 19 of 44 cases (43.2%) and was significantly correlated with β-catenin accumulation (p = .003). Conclusions. These findings suggest that β-catenin, which, in cooperation with cyclin D1, plays crucial role in the Wnt-signaling pathway, may also contribute to the adverse outcome and high-grade tumor staging of MEC.

Original languageEnglish
Pages (from-to)577-584
Number of pages8
JournalHead and Neck
Volume29
Issue number6
DOIs
Publication statusPublished - Jun 1 2007

Fingerprint

Mucoepidermoid Carcinoma
Catenins
Cyclin D1
Neck
Head
Neoplasms
bcl-1 Genes
APC Genes
Wnt Signaling Pathway
Codon
Adenomatous Polyposis Coli Protein
Polymerase Chain Reaction
Neoplasm Staging
Viperidae
Point Mutation

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

β-catenin nuclear accumulation in head and neck mucoepidermoid carcinoma : Its role in cyclin D1 overexpression and tumor progression. / Shiratsuchi, Hideki; Nakashima, Torahiko; Hirakawa, Naoya; Toh, Satoshi; Nakagawa, Takashi; Saito, Tsuyoshi; Tsuneyoshi, Masazumi; Komune, Shizuo.

In: Head and Neck, Vol. 29, No. 6, 01.06.2007, p. 577-584.

Research output: Contribution to journalArticle

Shiratsuchi, H, Nakashima, T, Hirakawa, N, Toh, S, Nakagawa, T, Saito, T, Tsuneyoshi, M & Komune, S 2007, 'β-catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: Its role in cyclin D1 overexpression and tumor progression', Head and Neck, vol. 29, no. 6, pp. 577-584. https://doi.org/10.1002/hed.20583
Shiratsuchi, Hideki ; Nakashima, Torahiko ; Hirakawa, Naoya ; Toh, Satoshi ; Nakagawa, Takashi ; Saito, Tsuyoshi ; Tsuneyoshi, Masazumi ; Komune, Shizuo. / β-catenin nuclear accumulation in head and neck mucoepidermoid carcinoma : Its role in cyclin D1 overexpression and tumor progression. In: Head and Neck. 2007 ; Vol. 29, No. 6. pp. 577-584.
@article{70c8032aa8134dbab592dee5390b7bf1,
title = "β-catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: Its role in cyclin D1 overexpression and tumor progression",
abstract = "Background. Nuclear/cytoplasmic accumulation of β-catenin is mainly regulated by its degradation, which is initiated by interaction with adenomatous polyposis coli (APC) protein. Accumulation of β-catenin activates the transcription of 1 of the target oncogenic genes, cyclin D1, in the Wnt/Wingless pathway. The role of β-catenin and cyclin D1 in this pathway has not been previously studied in head and neck mucoepidermoid carcinoma (MEC). This study investigates abnormalities of β-catenin and the APC gene in MEC and correlates the patterns of cyclin D1 overexpression and nuclear/cytoplasmic accumulation of β-catenin with the clinical outcome. Methods. Mutations of the β-catenin and APC genes, as well as overexpression of cyclin D1, were investigated by polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) in tissue samples from 44 cases of MEC. In addition, we employed differential PCR method to detect amplification of the cyclin D1 gene. Furthermore, the overexpression of cyclin D1 and nuclear/cytoplasmic accumulation of β-catenin was examined by immunohistochemistry, and any correlation with clinicopathologic parameters was evaluated. Results. Nuclear/cytoplasmic accumulation of β-catenin was observed in 6 of 44 MEC cases (13.6{\%}), 5 of which were high-grade MEC, while the other 1 case was intermediate-grade tumor. Mutational analysis of exon 3 of the β-catenin gene revealed that 4 of 26 cases (15.4{\%}) contained point mutations (3 in codon 32, GAC [Asp] to GGC [Gly]; 1 in codon 42, ACA [Thr] to ATA [Ile]), and all these 4 cases showed β-catenin accumulation immunohistochemically. The nuclear/cytoplasmic accumulation of β-catenin was significantly correlated with the adverse outcome of patients (p = .011). Two APC gene alterations were detected in 2 cases of low-grade MEC, where there was no β-catenin nuclear accumulation. Amplification of the cyclin D1 gene was observed in 10 of 26 cases (38.5{\%}). Cyclin D1 overexpression was recognized in 19 of 44 cases (43.2{\%}) and was significantly correlated with β-catenin accumulation (p = .003). Conclusions. These findings suggest that β-catenin, which, in cooperation with cyclin D1, plays crucial role in the Wnt-signaling pathway, may also contribute to the adverse outcome and high-grade tumor staging of MEC.",
author = "Hideki Shiratsuchi and Torahiko Nakashima and Naoya Hirakawa and Satoshi Toh and Takashi Nakagawa and Tsuyoshi Saito and Masazumi Tsuneyoshi and Shizuo Komune",
year = "2007",
month = "6",
day = "1",
doi = "10.1002/hed.20583",
language = "English",
volume = "29",
pages = "577--584",
journal = "Head and Neck Surgery",
issn = "1043-3074",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - β-catenin nuclear accumulation in head and neck mucoepidermoid carcinoma

T2 - Its role in cyclin D1 overexpression and tumor progression

AU - Shiratsuchi, Hideki

AU - Nakashima, Torahiko

AU - Hirakawa, Naoya

AU - Toh, Satoshi

AU - Nakagawa, Takashi

AU - Saito, Tsuyoshi

AU - Tsuneyoshi, Masazumi

AU - Komune, Shizuo

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Background. Nuclear/cytoplasmic accumulation of β-catenin is mainly regulated by its degradation, which is initiated by interaction with adenomatous polyposis coli (APC) protein. Accumulation of β-catenin activates the transcription of 1 of the target oncogenic genes, cyclin D1, in the Wnt/Wingless pathway. The role of β-catenin and cyclin D1 in this pathway has not been previously studied in head and neck mucoepidermoid carcinoma (MEC). This study investigates abnormalities of β-catenin and the APC gene in MEC and correlates the patterns of cyclin D1 overexpression and nuclear/cytoplasmic accumulation of β-catenin with the clinical outcome. Methods. Mutations of the β-catenin and APC genes, as well as overexpression of cyclin D1, were investigated by polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) in tissue samples from 44 cases of MEC. In addition, we employed differential PCR method to detect amplification of the cyclin D1 gene. Furthermore, the overexpression of cyclin D1 and nuclear/cytoplasmic accumulation of β-catenin was examined by immunohistochemistry, and any correlation with clinicopathologic parameters was evaluated. Results. Nuclear/cytoplasmic accumulation of β-catenin was observed in 6 of 44 MEC cases (13.6%), 5 of which were high-grade MEC, while the other 1 case was intermediate-grade tumor. Mutational analysis of exon 3 of the β-catenin gene revealed that 4 of 26 cases (15.4%) contained point mutations (3 in codon 32, GAC [Asp] to GGC [Gly]; 1 in codon 42, ACA [Thr] to ATA [Ile]), and all these 4 cases showed β-catenin accumulation immunohistochemically. The nuclear/cytoplasmic accumulation of β-catenin was significantly correlated with the adverse outcome of patients (p = .011). Two APC gene alterations were detected in 2 cases of low-grade MEC, where there was no β-catenin nuclear accumulation. Amplification of the cyclin D1 gene was observed in 10 of 26 cases (38.5%). Cyclin D1 overexpression was recognized in 19 of 44 cases (43.2%) and was significantly correlated with β-catenin accumulation (p = .003). Conclusions. These findings suggest that β-catenin, which, in cooperation with cyclin D1, plays crucial role in the Wnt-signaling pathway, may also contribute to the adverse outcome and high-grade tumor staging of MEC.

AB - Background. Nuclear/cytoplasmic accumulation of β-catenin is mainly regulated by its degradation, which is initiated by interaction with adenomatous polyposis coli (APC) protein. Accumulation of β-catenin activates the transcription of 1 of the target oncogenic genes, cyclin D1, in the Wnt/Wingless pathway. The role of β-catenin and cyclin D1 in this pathway has not been previously studied in head and neck mucoepidermoid carcinoma (MEC). This study investigates abnormalities of β-catenin and the APC gene in MEC and correlates the patterns of cyclin D1 overexpression and nuclear/cytoplasmic accumulation of β-catenin with the clinical outcome. Methods. Mutations of the β-catenin and APC genes, as well as overexpression of cyclin D1, were investigated by polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) in tissue samples from 44 cases of MEC. In addition, we employed differential PCR method to detect amplification of the cyclin D1 gene. Furthermore, the overexpression of cyclin D1 and nuclear/cytoplasmic accumulation of β-catenin was examined by immunohistochemistry, and any correlation with clinicopathologic parameters was evaluated. Results. Nuclear/cytoplasmic accumulation of β-catenin was observed in 6 of 44 MEC cases (13.6%), 5 of which were high-grade MEC, while the other 1 case was intermediate-grade tumor. Mutational analysis of exon 3 of the β-catenin gene revealed that 4 of 26 cases (15.4%) contained point mutations (3 in codon 32, GAC [Asp] to GGC [Gly]; 1 in codon 42, ACA [Thr] to ATA [Ile]), and all these 4 cases showed β-catenin accumulation immunohistochemically. The nuclear/cytoplasmic accumulation of β-catenin was significantly correlated with the adverse outcome of patients (p = .011). Two APC gene alterations were detected in 2 cases of low-grade MEC, where there was no β-catenin nuclear accumulation. Amplification of the cyclin D1 gene was observed in 10 of 26 cases (38.5%). Cyclin D1 overexpression was recognized in 19 of 44 cases (43.2%) and was significantly correlated with β-catenin accumulation (p = .003). Conclusions. These findings suggest that β-catenin, which, in cooperation with cyclin D1, plays crucial role in the Wnt-signaling pathway, may also contribute to the adverse outcome and high-grade tumor staging of MEC.

UR - http://www.scopus.com/inward/record.url?scp=34548235778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548235778&partnerID=8YFLogxK

U2 - 10.1002/hed.20583

DO - 10.1002/hed.20583

M3 - Article

VL - 29

SP - 577

EP - 584

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 1043-3074

IS - 6

ER -